Stockholders' Equity (Details 5) |
9 Months Ended |
|---|---|
|
Jun. 30, 2019
$ / shares
shares
| |
| Outstanding, beginning | $ 10.13 |
| Expired/ Forfeited | 5.34 |
| Outstanding, ending | $ 5.05 |
| Warrant [Member] | |
| Outstanding, beginning | shares | 6,075,874 |
| Granted | shares | 194,354 |
| Expired/ Forfeited | shares | (555) |
| Outstanding, ending | shares | 6,269,673 |
| Outstanding, beginning | $ 4.53 |
| Granted | 1.02 |
| Expired/ Forfeited | 55.00 |
| Outstanding, ending | $ 4.41 |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. No definition available.
|
| X | ||||||||||
- Details
|